SSE: 601607
Announcement on Approval for Production of Isavuconazonium Sulfate for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
(601607)"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Isavuconazonium Sulfate for Injection
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
View original source (Shanghai Stock Exchange)
Earlier from Shanghai Pharmaceuticals Holding Co. Ltd. Class A
- "Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- "Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Ruxolitinib Phosphate Tablets
- "Shanghai Pharmaceuticals Holding Co., Ltd."Semi-annual Report for 2026
- "Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Resolutions of the 3rd Meeting of the 9th Board of Directors